4//SEC Filing
Gordon David N. 4
Accession 0001209191-21-045899
CIK 0001557746other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 6:03 PM ET
Size
7.3 KB
Accession
0001209191-21-045899
Insider Transaction Report
Form 4
Gordon David N.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-07-02+6,000→ 150,078 total - Exercise/Conversion
Restricted Stock Units
2021-07-02−6,000→ 6,000 total→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The shares underlying these restricted stock units vest over a period of four years, with 25% vesting on the first, second, third and fourth anniversaries of the date of grant, beginning on July 2, 2019 and subject to the reporting person's continuous service with the issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001751167
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 6:03 PM ET
- Size
- 7.3 KB